Leawell International Ltd was incorporated in 1993 with its base in
Hong Kong, specializing in marketing and distribution of
pharmaceutical, chemical raw materials, intermediates,
pharmaceutical finished dosages and medical equipment in and out of
Our company acts as the bridge for foreign companies of China in
the Pharmaceutical Industry. Acting as an agent and distributor for
API and finish formulation for various multinational famous
pharmaceutical companies in countries such as Italy, Germany,
Spain, Austria, Netherlands, France, Mexico, Slovenia, Korea,
India, Taiwan, etc.
For these API and F/F, we have obtained 98 Import Drug
Licenses. Among them, 45 items of which we registered and act as
agent; 34 items are under application by us. Presently, we submitte
an average of 10 import drug applications every year. We have
a group of specialists working on registration from the very start:
market survey, translation, communication, quality feedback,
importation, following up and reviewing of dossier according to the
Chinese Registering Rule, inspecting of samples, exchanging views
with CDE reviewers, etc.
Lately, we have signed agreements with several esteemed Chinese
manufacturers on 19 projects, which link our API IDL application
with their F/F manufacturing license application. In the meantime,
we have 6 projects on finished formulation IDL application, and
many projects are under discussions.
At the same time, we are also active in exporting API and
Intermediates to Europe, and also helping local manufacturers for
DMF and COS registration. Recently, Guangzhou Baiyunshan
Pharmaceutical has authorized us as an exclusive agent for handling
import and export for the European manufacturers. We actively
promote Chinese manufactured pharmaceuticals and are renowned in
China for antibiotics and the import and export business.
We established a Joint Venture in Shantou in 2002 Shantou
Antibiotics Pharmaceutical Co. Ltd., producing antibiotics API.
We are not only an cooperation with many esteemed pharmaceutical
manufacturers in mainland China, but also acting as an agent of
sales and registration for them to help the Chinese pharmaceutical
companies in registration of their Chinese medicine products in
Leawell has established an extensive and long-term cooperation
relationship with the pharmaceutical companies and manufacturers in
and out of China. We are experienced in scale production of a
variety of sterile product dosage forms, including sterile
injection powder, injection, tablets, capsules, suppository,
ointments, eye-drop, etc. We are also experienced in processing the
pharmaceutical and chemical raw materials and intermediates in and
out of China.
Our subsidiary, Guangdong Leawell Pharmaceutical Co. Ltd., owns
operation licenses for all types of API, finished dosages and
medical equipments with GSP certificate. While our subsidiary in
Beijing, Beijing Century Leawell Pharmaceutical Development Ltd, is
responsible for the IDL, COS and DMF applications and technical
We also have a subsidiary in Shanghai, which is responsible for the
export. Over the past 15 years, Leawell has established an
extensive and long-term cooperation relationship with hundreds of
reputable pharmaceutical companies and manufacturers in China and
all over the world.